Clinical Trial Update: An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection [Phase 2]

View source ↗

Summary

A Phase 2 extension study evaluating the safety and efficacy of celgosivir with peginterferon alfa-2b, with or without ribavirin, in patients with chronic hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Celgosivir (celgosivir)
• Peginterferon alfa-2b (Pegasys) (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: BioWest Therapeutics Inc | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED